Ameriprise’s Akoustis Technologies Inc AKTS Stock Holding History

Ameriprise’s Portfolio AKTS Stock Details AKTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-116,221	Closed	-$370K	–	3985
2023 Q2	$370K	Buy	+116,221	New	+$356K	﹤0.01%	3544

Other funds holding AKTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

HIM

Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameriprise's AKTS Position: Q3 2023 in Review

Ameriprise sold out of Akoustis Technologies Inc (AKTS) in Q3 2023, closing a stake of 116,221 shares — an estimated $370K sold.

Ameriprise first reported a position in AKTS in Q2 2023 and held it in 1 quarter. The position peaked at $370K in Q2 2023. 120 funds tracked by Wall St. Rank hold AKTS as of Q3 2023.

Ameriprise reported no remaining Akoustis Technologies Inc position as of Q3 2023 after selling out during the quarter.
Ameriprise sold 116,221 Akoustis Technologies Inc shares in Q3 2023, an estimated $370K.
Ameriprise first reported a position in Akoustis Technologies Inc in Q2 2023 and held it in 1 quarter.
Ameriprise's Akoustis Technologies Inc position peaked at $370K in Q2 2023.
120 funds tracked by Wall St. Rank held Akoustis Technologies Inc as of Q3 2023.

Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.